19 results
424B5
CGTX
Cognition Therapeutics Inc
13 Mar 24
Prospectus supplement for primary offering
4:04pm
and restated bylaws, procedures for our stockholder meetings, the classified board, director liability, and exclusive forum for proceedings.
Dividends. Subject
424B5
CGTX
Cognition Therapeutics Inc
11 Mar 24
Prospectus supplement for primary offering
4:06pm
stockholder meetings, the classified board, director liability, and exclusive forum for proceedings.
Dividends. Subject to preferences that may
424B4
CGTX
Cognition Therapeutics Inc
8 Jan 24
Prospectus supplement with pricing info
4:11pm
, the classified board, director liability, and exclusive forum for proceedings.
Dividends. Subject to preferences that may be applicable to any
S-3
owvlkzn84u
23 Dec 22
Shelf registration
4:16pm
424B4
9qowf97x5fkshz
14 Nov 22
Prospectus supplement with pricing info
6:02am
DRS
xhrph05hjoz64qhgiu
20 Oct 22
Draft registration statement
12:00am
10-K
nht3k6k4tzc8h p9o
30 Mar 22
Annual report
7:40am
10-Q
syjj10z sm61msq5
17 Nov 21
Quarterly report
5:15pm
8-K
tao3q02qdzm4a z8w6
14 Oct 21
Amendments to Articles of Incorporation or Bylaws
4:41pm
424B4
ormb5 3ff
12 Oct 21
Prospectus supplement with pricing info
4:11pm
S-1
pvdp 5w6dw
19 Jul 21
IPO registration
7:02am
DRS/A
j71j0rqrkifa kk
23 Jun 21
Draft registration statement (amended)
12:00am
DRS
onx7pcqowffbaoboa12q
7 May 21
Draft registration statement
12:00am
- Prev
- 1
- Next